IP Library Granted Patent US 12,239,555
Granted Patent B2
US 12,239,555 · App. 17/372,940 · Granted Mar 4, 2025

Stent and method of making same

Inventors: Scott P. Carpenter (Fremont, CA); Julio C. Palmaz (Napa, CA)
Assignee: Vactronix Scientific, LLC
A61F2/915A61F2002/91533A61F2002/91541A61F2002/91558A61F2002/91566A61F2210/0014A61F2230/0054A61F2240/001A61F2250/0067A61F2250/0068A61F2250/0098A61L2420/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,239,555
App. No.
17/372,940
Granted
Mar 4, 2025
Kind
B2
Abstract

A stent for vascular interventions having a hybrid open cell geometry. Variants of the stent include bare metal stents and drug-eluting stents. Embodiments of the stent include end projections for radiopaque markers or a discontinuous partial radiopaque coating on low-stress or low-strain regions of the peripheral stent. The stents of the invention are characterized by having thin walls, nested rows of struts, high expansion ratio, high and uniform radial force over entire diametric size and length of device, crush resistance up to and including about 90% of its fully expanded diameter, high fatigue resistance and high corrosion resistance.

Claims (24)

1. A stent having an outer abluminal surface and an inner luminal surface, comprising:

a. A plurality of generally sinusoidal circumferential ring members having peaks and valleys;

b. A plurality of bridge members interconnecting adjacent pairs of sinusoidal circumferential ring members;

c. A plurality of projection members extending from at least one of a proximal and a distal generally sinusoidal circumferential ring member at proximal and/or distal ends of the stent, the projection members further comprising open frame members capable of being engaged with radiopaque cuff members thereupon;

d. A plurality of volume-enhancing features formed in or on the outer abluminal surface of the stent and the plurality of projection members, wherein the plurality of volume-enhancing features further comprise elongate grooves have a depth between about 0.5 μm and about 10 μm; and

e. A drug eluting layer covering the entire outer abluminal surface of the stent and at least substantially or totally filling the plurality of volume-enhancing features, wherein the drug eluting layer substantially fills the plurality of grooves and has a thickness of between about 3 μm to about 20 μm from the outer abluminal surface of the stent.

2. The stent of claim 1 , wherein each of the plurality of sinusoidal circumferential ring members is configured to nest with adjacent sinusoidal circumferential ring members when the stent is in a diametrically unexpanded state.

3. The stent of claim 1 , wherein the plurality of sinusoidal circumferential ring members further has a substantially zig-zag configuration.

4. The stent of claim 3 , further comprising an offset section intermediate circumferentially adjacent peaks and valleys of each circumferential ring member.

5. The stent of claim 1 , wherein the plurality of generally sinusoidal circumferential ring members and the plurality of bridge members have a wall thickness between about 50 μm and about 100 μm.

6. The stent of claim 1 , wherein the plurality of volume-enhancing features have a spacing of about 2 μm and about 10 μm between adjacent volume-enhancing features.

7. The stent of claim 1 , wherein each of the plurality of volume-enhancing features have a width between 0.5 and 10 μm.

8. The stent of claim 7 , wherein each of the plurality of volume-enhancing features have a width to depth ration between about 1:1 and 1:3.

9. The stent of claim 1 , wherein the plurality of volume-enhancing features are formed in the plurality of sinusoidal circumferential ring members and in the plurality of bridge members.

10. The stent of claim 1 , wherein each of the open frame members further comprises a substantially quadrilateral frame having a central open region.

11. The stent of claim 10 , further comprising a radiopaque cuff member joined to each of the plurality of projection members such that a portion of the radiopaque cuff member is coplanar with the projection member to which it is joined.

12. The stent of claim 11 , wherein the radiopaque cuff member has a portion thereof recessed within the central open region.

13. The stent of claim 1 , further comprising a radiopaque coating on at least a portion of the outer abluminal surface of the stent.

14. The stent of claim 1 , wherein the plurality of circumferential ring members and the plurality of bridge members further define a plurality of open cells.

15. The stent of claim 14 , wherein the plurality of open cells further comprises at least two different open cell configurations.

16. The stent of claim 15 , where the at least two different open cell configurations further comprise a first open cell configuration positioned at or proximate to opposing ends of the stent and a second open cell configuration positioned along an intermediate portion of the stent.

17. The stent of claim 16 , wherein the first open cell configuration further comprises a generally V-shaped open cell configuration.

18. The stent of claim 17 , wherein the second open cell configuration further comprises a generally Z-shaped open cell configuration.

19. The stent of claim 1 , wherein the plurality of elongate grooves are oriented substantially parallel to a longitudinal axis of the stent.

Continuity (2)
Division 16287519 · Feb 27, 2019
Related Publication 20220054288A1 · Feb 24, 2022
References Cited (27)
US 6231598B1 · Berry et al. · 2001 [cited by applicant]
US 6805898B1 · Wu et al. · 2004 [cited by applicant]
US 7744644B2 · Weber et al. · 2010 [cited by applicant]
US D665079S · Zago · 2012 [cited by applicant]
US D665080S · Zago · 2012 [cited by applicant]
US 8353949B2 · Weber et al. · 2013 [cited by applicant]
US D723165S · Chanduszko · 2015 [cited by applicant]
US D723166S · Igaki et al. · 2015 [cited by applicant]
US 9138512B2 · Ferrari et al. · 2015 [cited by applicant]
US D740427S · McDonnell et al. · 2015 [cited by applicant]
US 11058564B2 · Carpenter · 2021 [cited by examiner]
US 20030055485A1 · Lee et al. · 2003 [cited by applicant]
US 20040225347A1 · Lang · 2004 [cited by applicant]
US 20040243097A1 · Falotico et al. · 2004 [cited by applicant]
US 20040254637A1 · Yang · 2004 [cited by examiner]
US 20050228477A1 · Grainger et al. · 2005 [cited by applicant]
US 20100305682A1 · Furst · 2010 [cited by applicant]
US 20110106239A1 · Goto · 2011 [cited by applicant]
US 20110190871A1 · Trollsas et al. · 2011 [cited by applicant]
US 20140277391A1 · Layman et al. · 2014 [cited by applicant]
WO WO2006026781A2 · 2006 [cited by examiner]
WO WO2006099450A2 · 2006 [cited by examiner]
Feiring, AJ, “Below-the-Knee Drug-Eluting Stents,” Endovascular Today, pp. 65-72 (Aug. 2011). [cited by applicant]
U.S. Department of Health and Human Services Food and Drug Administration, “Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems,” Guidance for Industry and FD… [cited by applicant]
U.S. Department of Health and Human Services Food and Drug Administration, “Select Updates for Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems,” Guidance … [cited by applicant]
PCT Written Opinion of the International Searching Authority, International Application No. PCT/US2020/019984 (Jul. 6, 2020). [cited by applicant]
PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration. International Application No. PCT/US2020/19984. (Jul. 6, 2020). [cited by applicant]